{"id":92254,"date":"2026-01-08T22:07:28","date_gmt":"2026-01-08T13:07:28","guid":{"rendered":"https:\/\/www.marketresearch.co.jp\/insights\/t-cell-immunotherapy-market-mordor\/"},"modified":"2026-10-06T16:23:53","modified_gmt":"2026-10-06T07:23:53","slug":"t-cell-immunotherapy-market-mordor","status":"publish","type":"post","link":"https:\/\/www.marketresearch.co.jp\/insights\/t-cell-immunotherapy-market-mordor\/","title":{"rendered":"T\u7d30\u80de\u514d\u75ab\u7642\u6cd5\u5e02\u5834\u898f\u6a21\u30fb\u30b7\u30a7\u30a2\u5206\u6790 &#8211; \u6210\u9577\u52d5\u5411\u3068\u4e88\u6e2c (2025\u5e74\uff5e2030\u5e74)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2026\/01\/t-cell-immunotherapy-market-1757570616601-major-players.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.marketresearch.co.jp\/insights\/wp-content\/uploads\/2026\/01\/t-cell-immunotherapy-market-size-image-1757567989854.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \u306f\u3058\u3081\u306b<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \u8abf\u67fb\u306e\u524d\u63d0\u3068\u5e02\u5834\u306e\u5b9a\u7fa9<\/li>\n<li class=\"toc-level-2\">1.2 \u8abf\u67fb\u7bc4\u56f2<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \u8abf\u67fb\u65b9\u6cd5<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \u30a8\u30b0\u30bc\u30af\u30c6\u30a3\u30d6\u30b5\u30de\u30ea\u30fc<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \u5e02\u5834\u6982\u6cc1<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \u5e02\u5834\u6982\u8981<\/li>\n<li class=\"toc-level-2\">4.2 \u5e02\u5834\u306e\u63a8\u9032\u8981\u56e0\n<ul>\n<li class=\"toc-level-3\">4.2.1 \u4e16\u754c\u7684\u306a\u764c\u306e\u8ca0\u62c5\u306e\u5897\u52a0\u3068\u9ad8\u9f62\u5316<\/li>\n<li class=\"toc-level-3\">4.2.2 T\u7d30\u80de\u7642\u6cd5\u306e\u9069\u5fdc\u62e1\u5927\u3068\u30e9\u30d9\u30eb\u62e1\u5f35<\/li>\n<li class=\"toc-level-3\">4.2.3 \u6709\u5229\u306a\u898f\u5236\u7d4c\u8def\u3068\u8fc5\u901f\u627f\u8a8d\u30d7\u30ed\u30b0\u30e9\u30e0<\/li>\n<li class=\"toc-level-3\">4.2.4 \u7d30\u80de\u30fb\u907a\u4f1d\u5b50\u6cbb\u7642\u30a4\u30f3\u30d5\u30e9\u3078\u306e\u6295\u8cc7\u5897\u52a0<\/li>\n<li class=\"toc-level-3\">4.2.5 \u7d30\u80de\u5de5\u5b66\u3068\u88fd\u9020\u81ea\u52d5\u5316\u306b\u304a\u3051\u308b\u6280\u8853\u7684\u9032\u6b69<\/li>\n<li class=\"toc-level-3\">4.2.6 \u88fd\u85ac\u3001\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3001\u5b66\u8853\u754c\u306b\u308f\u305f\u308b\u6226\u7565\u7684\u63d0\u643a\u3068\u30a2\u30e9\u30a4\u30a2\u30f3\u30b9<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \u5e02\u5834\u306e\u963b\u5bb3\u8981\u56e0\n<ul>\n<li class=\"toc-level-3\">4.3.1 \u9ad8\u984d\u306a\u6cbb\u7642\u8cbb\u3068\u4e0d\u78ba\u5b9f\u306a\u511f\u9084\u72b6\u6cc1<\/li>\n<li class=\"toc-level-3\">4.3.2 \u8907\u96d1\u306a\u88fd\u9020\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u3068\u751f\u7523\u80fd\u529b\u306e\u5236\u7d04<\/li>\n<li class=\"toc-level-3\">4.3.3 \u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u653e\u51fa\u75c7\u5019\u7fa4\u3084\u795e\u7d4c\u6bd2\u6027\u3092\u542b\u3080\u5b89\u5168\u6027\u3078\u306e\u61f8\u5ff5<\/li>\n<li class=\"toc-level-3\">4.3.4 \u4ee3\u66ff\u514d\u75ab\u7642\u6cd5\u30e2\u30c0\u30ea\u30c6\u30a3\u304b\u3089\u306e\u7af6\u4e89\u5727\u529b<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u5206\u6790<\/li>\n<li class=\"toc-level-2\">4.5 \u898f\u5236\u72b6\u6cc1<\/li>\n<li class=\"toc-level-2\">4.6 \u6280\u8853\u7684\u5c55\u671b<\/li>\n<li class=\"toc-level-2\">4.7 \u30dd\u30fc\u30bf\u30fc\u306e5\u3064\u306e\u529b\u5206\u6790\n<ul>\n<li class=\"toc-level-3\">4.7.1 \u4f9b\u7d66\u8005\u306e\u4ea4\u6e09\u529b<\/li>\n<li class=\"toc-level-3\">4.7.2 \u8cb7\u3044\u624b\u306e\u4ea4\u6e09\u529b<\/li>\n<li class=\"toc-level-3\">4.7.3 \u65b0\u898f\u53c2\u5165\u306e\u8105\u5a01<\/li>\n<li class=\"toc-level-3\">4.7.4 \u4ee3\u66ff\u54c1\u306e\u8105\u5a01<\/li>\n<li class=\"toc-level-3\">4.7.5 \u7af6\u4e89\u4e0a\u306e\u5bfe\u6297\u95a2\u4fc2<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \u5e02\u5834\u898f\u6a21\u3068\u6210\u9577\u4e88\u6e2c\uff08\u91d1\u984d\uff09<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \u6cbb\u7642\u30bf\u30a4\u30d7\u5225\n<ul>\n<li class=\"toc-level-3\">5.1.1 CAR-T<\/li>\n<li class=\"toc-level-3\">5.1.2 TCR-T<\/li>\n<li class=\"toc-level-3\">5.1.3 TIL<\/li>\n<li class=\"toc-level-3\">5.1.4 ?? T\u7d30\u80de<\/li>\n<li class=\"toc-level-3\">5.1.5 \u305d\u306e\u4ed6\uff08CAAR-T\u3001MILs\uff09<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \u9069\u5fdc\u75c7\u5225\n<ul>\n<li class=\"toc-level-3\">5.2.1 \u8840\u6db2\u60aa\u6027\u816b\u760d<\/li>\n<li class=\"toc-level-3\">5.2.2 \u56fa\u5f62\u816b\u760d<\/li>\n<li class=\"toc-level-3\">5.2.3 \u81ea\u5df1\u514d\u75ab\u75be\u60a3<\/li>\n<li class=\"toc-level-3\">5.2.4 \u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7<\/li>\n<li class=\"toc-level-3\">5.2.5 \u305d\u306e\u4ed6\uff08\u5e0c\u5c11\u304c\u3093\uff09<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \u5730\u57df\u5225\n<ul>\n<li class=\"toc-level-3\">5.3.1 \u5317\u7c73<\/li>\n<li class=\"toc-level-4\">5.3.1.1 \u7c73\u56fd<\/li>\n<li class=\"toc-level-4\">5.3.1.2 \u30ab\u30ca\u30c0<\/li>\n<li class=\"toc-level-4\">5.3.1.3 \u30e1\u30ad\u30b7\u30b3<\/li>\n<li class=\"toc-level-3\">5.3.2 \u6b27\u5dde<\/li>\n<li class=\"toc-level-4\">5.3.2.1 \u30c9\u30a4\u30c4<\/li>\n<li class=\"toc-level-4\">5.3.2.2 \u82f1\u56fd<\/li>\n<li class=\"toc-level-4\">5.3.2.3 \u30d5\u30e9\u30f3\u30b9<\/li>\n<li class=\"toc-level-4\">5.3.2.4 \u30a4\u30bf\u30ea\u30a2<\/li>\n<li class=\"toc-level-4\">5.3.2.5 \u30b9\u30da\u30a4\u30f3<\/li>\n<li class=\"toc-level-4\">5.3.2.6 \u305d\u306e\u4ed6\u306e\u6b27\u5dde<\/li>\n<li class=\"toc-level-3\">5.3.3 \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<\/li>\n<li class=\"toc-level-4\">5.3.3.1 \u4e2d\u56fd<\/li>\n<li class=\"toc-level-4\">5.3.3.2 \u65e5\u672c<\/li>\n<li class=\"toc-level-4\">5.3.3.3 \u30a4\u30f3\u30c9<\/li>\n<li class=\"toc-level-4\">5.3.3.4 \u97d3\u56fd<\/li>\n<li class=\"toc-level-4\">5.3.3.5 \u30aa\u30fc\u30b9\u30c8\u30e9\u30ea\u30a2<\/li>\n<li class=\"toc-level-4\">5.3.3.6 \u305d\u306e\u4ed6\u306e\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b<\/li>\n<li class=\"toc-level-3\">5.3.4 \u4e2d\u6771 &amp; \u30a2\u30d5\u30ea\u30ab<\/li>\n<li class=\"toc-level-4\">5.3.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.3.4.2 \u5357\u30a2\u30d5\u30ea\u30ab<\/li>\n<li class=\"toc-level-4\">5.3.4.3 \u305d\u306e\u4ed6\u306e\u4e2d\u6771 &amp; \u30a2\u30d5\u30ea\u30ab<\/li>\n<li class=\"toc-level-3\">5.3.5 \u5357\u7c73<\/li>\n<li class=\"toc-level-4\">5.3.5.1 \u30d6\u30e9\u30b8\u30eb<\/li>\n<li class=\"toc-level-4\">5.3.5.2 \u30a2\u30eb\u30bc\u30f3\u30c1\u30f3<\/li>\n<li class=\"toc-level-4\">5.3.5.3 \u305d\u306e\u4ed6\u306e\u5357\u7c73<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \u7af6\u5408\u60c5\u52e2<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \u5e02\u5834\u96c6\u4e2d\u5ea6<\/li>\n<li class=\"toc-level-2\">6.2 \u5e02\u5834\u30b7\u30a7\u30a2\u5206\u6790<\/li>\n<li class=\"toc-level-2\">6.3 \u4f01\u696d\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb {(\u30b0\u30ed\u30fc\u30d0\u30eb\u6982\u8981\u3001\u5e02\u5834\u6982\u8981\u3001\u4e3b\u8981\u30bb\u30b0\u30e1\u30f3\u30c8\u3001\u5229\u7528\u53ef\u80fd\u306a\u8ca1\u52d9\u60c5\u5831\u3001\u6226\u7565\u60c5\u5831\u3001\u4e3b\u8981\u4f01\u696d\u306e\u5e02\u5834\u30e9\u30f3\u30ad\u30f3\u30b0\/\u30b7\u30a7\u30a2\u3001\u88fd\u54c1 &amp; \u30b5\u30fc\u30d3\u30b9\u3001\u304a\u3088\u3073\u6700\u8fd1\u306e\u52d5\u5411\u3092\u542b\u3080)}\n<ul>\n<li class=\"toc-level-3\">6.3.1 Novartis AG<\/li>\n<li class=\"toc-level-3\">6.3.2 Gilead Sciences (Kite Pharma)<\/li>\n<li class=\"toc-level-3\">6.3.3 Bristol Myers Squibb<\/li>\n<li class=\"toc-level-3\">6.3.4 Johnson &amp; Johnson \/ Legend Biotech<\/li>\n<li class=\"toc-level-3\">6.3.5 Iovance Biotherapeutics<\/li>\n<li class=\"toc-level-3\">6.3.6 Adaptimmune Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.7 Allogene Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.8 Cellectis SA<\/li>\n<li class=\"toc-level-3\">6.3.9 CRISPR Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.10 TCR2 Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.11 Atara Biotherapeutics<\/li>\n<li class=\"toc-level-3\">6.3.12 Autolus Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.13 Bluebird Bio<\/li>\n<li class=\"toc-level-3\">6.3.14 Caribou Biosciences<\/li>\n<li class=\"toc-level-3\">6.3.15 Poseida Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.16 Fate Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.17 ImmunityBio (NantKwest)<\/li>\n<li class=\"toc-level-3\">6.3.18 Turnstone Biologics<\/li>\n<li class=\"toc-level-3\">6.3.19 Sorrento Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.20 BeiGene Ltd.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \u5e02\u5834\u6a5f\u4f1a &amp; \u5c06\u6765\u5c55\u671b<\/p>\n","protected":false},"excerpt":{"rendered":"<p>T\u7d30\u80de\u514d\u75ab\u7642\u6cd5\u5e02\u5834\u306f\u30012025\u5e74\u304b\u30892030\u5e74\u306b\u304b\u3051\u3066\u5927\u5e45\u306a\u6210\u9577\u304c\u898b\u8fbc\u307e\u308c\u3066\u304a\u308a\u3001\u305d\u306e\u5e02\u5834\u898f\u6a21\u306f2025\u5e74\u306e39.4\u5104\u7c73\u30c9\u30eb\u304b\u3089\u30012030\u5e74\u306b\u306f327.5\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u671f\u9593\u306b\u304a\u3051\u308b\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff09\u306f35.30%\u3068\u975e\u5e38\u306b\u9ad8\u304f\u3001\u7279\u306b\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u304c\u6700\u3082\u6025\u901f\u306a\u6210\u9577\u3092\u9042\u3052\u308b\u3068\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u73fe\u5728\u306e\u6700\u5927\u306e\u5e02\u5834\u306f\u5317\u7c73\u3067\u3042\u308a\u3001\u5e02\u5834\u306e\u96c6\u4e2d\u5ea6\u306f\u4e2d\u7a0b\u5ea6\u3067\u3059\u3002<\/p>\n<p>\u5e02\u5834\u5206\u6790\u306e\u6982\u8981<\/p>\n<p>\u3053\u306e\u5e02\u5834\u306e\u62e1\u5927\u306f\u3001\u4e3b\u306b\u816b\u760d\u5b66\u306b\u304a\u3051\u308bT\u7d30\u80de\u514d\u75ab\u7642\u6cd5\u306e\u63a1\u7528\u62e1\u5927\u3001\u3088\u308a\u65e9\u671f\u306e\u6cbb\u7642\u30e9\u30a4\u30f3\u3067\u306e\u627f\u8a8d\u3001\u511f\u9084\u5236\u5ea6\u306e\u52a0\u901f\u3001\u305d\u3057\u3066\u60a3\u8005\u9069\u683c\u6027\u306e\u62e1\u5927\u306b\u8d77\u56e0\u3057\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001\u5de5\u5b66\u7684\u306b\u8a2d\u8a08\u3055\u308c\u305f\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u304c\u56fa\u5f62\u816b\u760d\u306e\u6cbb\u7642\u306b\u3082\u9032\u51fa\u3057\u3001\u88fd\u9020\u30d7\u30ed\u30bb\u30b9\u306e\u81ea\u52d5\u5316\u304c\u9032\u3080\u3053\u3068\u3067\u3001\u30ed\u30c3\u30c8\u9593\u306e\u518d\u73fe\u6027\u304c\u5411\u4e0a\u3057\u3001\u751f\u7523\u30ea\u30fc\u30c9\u30bf\u30a4\u30e0\u304c\u77ed\u7e2e\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u7c73\u56fd\u98df\u54c1\u533b\u85ac\u54c1\u5c40\uff08FDA\uff09\u3068\u6b27\u5dde\u533b\u85ac\u54c1\u5e81\uff08EMA\uff09\u9593\u306e\u898f\u5236\u5354\u529b\u3082\u958b\u767a\u306e\u969c\u58c1\u3092\u4f4e\u6e1b\u3057\u3001\u6210\u679c\u30d9\u30fc\u30b9\u306e\u5951\u7d04\u304c\u5c0e\u5165\u3055\u308c\u308b\u3053\u3068\u3067\u3001\u9ad8\u984d\u306a\u6cbb\u7642\u8cbb\u306b\u5bfe\u3059\u308b\u652f\u6255\u3044\u5074\u306e\u61f8\u5ff5\u304c\u7de9\u548c\u3055\u308c\u3064\u3064\u3042\u308a\u307e\u3059\u3002\u7af6\u4e89\u306f\u6fc0\u5316\u3057\u3066\u304a\u308a\u3001\u30e1\u30fc\u30ab\u30fc\u306f\u30a2\u30ed\u30b8\u30a7\u30cb\u30c3\u30af\uff08\u4ed6\u5bb6\uff09\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u306b\u6ce8\u529b\u3057\u3001\u907a\u4f1d\u5b50\u7de8\u96c6\u306b\u3088\u308b\u5b89\u5168\u5bfe\u7b56\u3092\u7d71\u5408\u3057\u3001\u9577\u671f\u7684\u306aCDMO\uff08\u533b\u85ac\u54c1\u53d7\u8a17\u88fd\u9020\u958b\u767a\u6a5f\u95a2\uff09\u3068\u306e\u63d0\u643a\u3092\u901a\u3058\u3066\u751f\u7523\u80fd\u529b\u3092\u5f37\u5316\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u8981\u56e0\u304c\u8907\u5408\u7684\u306b\u4f5c\u7528\u3057\u3001T\u7d30\u80de\u514d\u75ab\u7642\u6cd5\u5e02\u5834\u306f\u4eca\u5f8c\u3082\u4e8c\u6841\u6210\u9577\u3092\u7d9a\u3051\u308b\u3068\u898b\u3089\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u4e3b\u8981\u306a\u30ec\u30dd\u30fc\u30c8\u306e\u30dd\u30a4\u30f3\u30c8<\/p>\n<p>*   \u6cbb\u7642\u30bf\u30a4\u30d7\u5225: \u30ad\u30e1\u30e9\u6297\u539f\u53d7\u5bb9\u4f53T\u7d30\u80de\uff08CAR-T\uff09\u304c2024\u5e74\u306eT\u7d30\u80de\u514d\u75ab\u7642\u6cd5\u5e02\u5834\u30b7\u30a7\u30a2\u306e95.7%\u3092\u5360\u3081\u307e\u3057\u305f\u3002\u4e00\u65b9\u3001\u30a2\u30ed\u30b8\u30a7\u30cb\u30c3\u30af\u88fd\u5264\u306f2025\u5e74\u304b\u30892030\u5e74\u306b\u304b\u3051\u306632.6%\u306eCAGR\u3067\u6210\u9577\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u9069\u5fdc\u75c7\u5225: \u8840\u6db2\u60aa\u6027\u816b\u760d\u304c2024\u5e74\u306e\u5e02\u5834\u898f\u6a21\u306e83.2%\u3092\u5360\u3081\u307e\u3057\u305f\u304c\u3001\u56fa\u5f62\u816b\u760d\u306f2030\u5e74\u307e\u3067\u306b35.4%\u306eCAGR\u3067\u6210\u9577\u3059\u308b\u898b\u8fbc\u307f\u3067\u3059\u3002<br \/>\n*   \u5730\u57df\u5225: \u5317\u7c73\u304c2024\u5e74\u306b53.4%\u306e\u5e02\u5834\u30b7\u30a7\u30a2\u3092\u5360\u3081\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u306f2030\u5e74\u307e\u3067\u306b25.2%\u306eCAGR\u3092\u8a18\u9332\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u306e\u6210\u9577\u8981\u56e0<\/p>\n<p>1.  \u4e16\u754c\u7684\u306a\u764c\u8ca0\u62c5\u306e\u5897\u52a0\u3068\u9ad8\u9f62\u5316: \u4e16\u754c\u7684\u306b\u764c\u306e\u7f79\u60a3\u7387\u304c\u5897\u52a0\u3057\u3066\u304a\u308a\u3001\u7279\u306b\u9ad8\u9f62\u5316\u304c\u9032\u3080\u7c73\u56fd\u3084\u6b27\u5dde\u3067\u306f\u8840\u6db2\u60aa\u6027\u816b\u760d\u306e\u60a3\u8005\u304c\u5897\u3048\u3066\u3044\u307e\u3059\u3002\u4e2d\u56fd\u3067\u306f300\u4ef6\u4ee5\u4e0a\u306eCAR-T\u6cbb\u9a13\u304c\u9032\u884c\u3057\u3066\u304a\u308a\u3001\u7c73\u56fd\u3068\u4e26\u3076\u30ea\u30fc\u30c0\u30fc\u30b7\u30c3\u30d7\u3092\u767a\u63ee\u3057\u3066\u3044\u307e\u3059\u3002\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u3067\u306f2040\u5e74\u307e\u3067\u306b\u764c\u60a3\u8005\u304c66%\u5897\u52a0\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u304a\u308a\u3001\u6cbb\u7642\u6cd5\u306e\u9700\u8981\u306f\u9ad8\u307e\u308b\u4e00\u65b9\u3067\u3059\u3002<br \/>\n2.  T\u7d30\u80de\u7642\u6cd5\u306e\u9069\u5fdc\u75c7\u62e1\u5927\u3068\u9069\u5fdc\u8ffd\u52a0: 2024\u5e74\u306b\u306f\u8ee2\u79fb\u6027\u6ed1\u819c\u8089\u816b\u306b\u5bfe\u3059\u308b\u30a2\u30d5\u30a1\u30df\u30c8\u30ec\u30b9\u30b8\u30fc\u30f3\u30fb\u30aa\u30fc\u30c8\u30ed\u30a4\u30bb\u30eb\u304cFDA\u306b\u627f\u8a8d\u3055\u308c\u3001T\u7d30\u80de\u53d7\u5bb9\u4f53\u88fd\u54c1\u3068\u3057\u3066\u521d\u3081\u3066\u56fa\u5f62\u816b\u760d\u306e\u58c1\u3092\u7a81\u7834\u3057\u307e\u3057\u305f\u3002\u627f\u8a8d\u306f\u3088\u308a\u65e9\u671f\u306e\u6cbb\u7642\u30e9\u30a4\u30f3\u3078\u3068\u79fb\u884c\u3059\u308b\u50be\u5411\u306b\u3042\u308a\u3001\u6cbb\u7642\u5bfe\u8c61\u3068\u306a\u308b\u60a3\u8005\u5c64\u304c\u62e1\u5927\u3057\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001\u30eb\u30fc\u30d7\u30b9\u306a\u3069\u306e\u81ea\u5df1\u514d\u75ab\u75be\u60a3\u3092\u6a19\u7684\u3068\u3059\u308b\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u3082\u591a\u69d8\u5316\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n3.  \u6709\u5229\u306a\u898f\u5236\u7d4c\u8def\u3068\u8fc5\u901f\u627f\u8a8d\u30d7\u30ed\u30b0\u30e9\u30e0: CoGenT Global\u30d1\u30a4\u30ed\u30c3\u30c8\u30d7\u30ed\u30b0\u30e9\u30e0\u306f\u3001\u898f\u5236\u5f53\u5c40\u9593\u306e\u5354\u529b\u3092\u4fc3\u9032\u3057\u3001\u7533\u8acb\u8981\u4ef6\u3092\u5408\u7406\u5316\u3057\u3001\u5be9\u67fb\u671f\u9593\u3092\u77ed\u7e2e\u3057\u3066\u3044\u307e\u3059\u3002RMAT\uff08\u518d\u751f\u533b\u7642\u5148\u9032\u6cbb\u7642\uff09\u3084PRIME\uff08\u512a\u5148\u533b\u85ac\u54c1\uff09\u6307\u5b9a\u306f\u81e8\u5e8a\u958b\u767a\u671f\u9593\u3092\u77ed\u7e2e\u3057\u30012025\u5e746\u6708\u306e\u81ea\u5df1\u7d30\u80de\u88fd\u54c1\u306b\u5bfe\u3059\u308bREMS\uff08\u30ea\u30b9\u30af\u8a55\u4fa1\u7de9\u548c\u6226\u7565\uff09\u64a4\u5ec3\u306f\u3001\u7279\u306b\u5730\u65b9\u306e\u6ce8\u5165\u30bb\u30f3\u30bf\u30fc\u306e\u904b\u7528\u8ca0\u62c5\u3092\u8efd\u6e1b\u3057\u307e\u3059\u3002\u898f\u5236\u5f53\u5c40\u306f2025\u5e74\u307e\u3067\u306b\u5e74\u959310\uff5e20\u4ef6\u306e\u65b0\u898f\u627f\u8a8d\u3092\u4e88\u6e2c\u3057\u3066\u304a\u308a\u3001\u5e02\u5834\u306e\u6025\u901f\u306a\u6210\u9577\u3092\u5f8c\u62bc\u3057\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n4.  \u7d30\u80de\u30fb\u907a\u4f1d\u5b50\u6cbb\u7642\u30a4\u30f3\u30d5\u30e9\u3078\u306e\u6295\u8cc7\u5897\u52a0: Bristol Myers Squibb\u304cCellares\u30683.8\u5104\u30c9\u30eb\u306e\u751f\u7523\u80fd\u529b\u4e88\u7d04\u5951\u7d04\u3092\u7d50\u3073\u3001\u81ea\u52d5\u5316\u3055\u308c\u305f\u9589\u9396\u7cfb\u30b7\u30b9\u30c6\u30e0\u3078\u306e\u79fb\u884c\u3092\u5f37\u8abf\u3057\u3066\u3044\u307e\u3059\u3002Gilead Sciences\u306f2026\u5e74\u307e\u3067\u306bCAR-T\u751f\u7523\u91cf\u30924\u500d\u306b\u3059\u308b\u8a08\u753b\u3067\u3059\u3002\u9ad8\u5bc6\u5ea6\u30de\u30a4\u30af\u30ed\u6d41\u4f53\u30d0\u30a4\u30aa\u30ea\u30a2\u30af\u30bf\u30fc\u306f\u751f\u7523\u91cf\u3092\u5411\u4e0a\u3055\u305b\u3001\u88fd\u9020\u30b3\u30b9\u30c8\u3092\u524a\u6e1b\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u30a4\u30f3\u30d5\u30e9\u6295\u8cc7\u306f\u3001\u6162\u6027\u7684\u306a\u751f\u7523\u67a0\u4e0d\u8db3\u3092\u89e3\u6d88\u3057\u3001\u81ea\u5df1\u7d30\u80de\u88fd\u54c1\u306e\u5546\u696d\u7684\u5b9f\u73fe\u53ef\u80fd\u6027\u3092\u9ad8\u3081\u3001\u30b9\u30b1\u30fc\u30e9\u30d6\u30eb\u306a\u30a2\u30ed\u30b8\u30a7\u30cb\u30c3\u30af\u88fd\u54c1\u306e\u5c0e\u5165\u306b\u5099\u3048\u3066\u3044\u307e\u3059\u3002<br \/>\n5.  \u7d30\u80de\u5de5\u5b66\u3068\u88fd\u9020\u81ea\u52d5\u5316\u306e\u6280\u8853\u9032\u6b69: (\u4e0a\u8a18\u306e\u30a4\u30f3\u30d5\u30e9\u6295\u8cc7\u3068\u95a2\u9023\u3057\u3001\u6280\u8853\u9769\u65b0\u304c\u751f\u7523\u52b9\u7387\u3068\u54c1\u8cea\u5411\u4e0a\u306b\u8ca2\u732e\u3057\u3066\u3044\u307e\u3059\u3002)<br \/>\n6.  \u88fd\u85ac\u3001\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3001\u5b66\u8853\u6a5f\u95a2\u9593\u306e\u6226\u7565\u7684\u63d0\u643a: (\u4e3b\u8981\u5e02\u5834\u3092\u4e2d\u5fc3\u306b\u3001\u4f01\u696d\u9593\u306e\u5354\u529b\u304c\u7814\u7a76\u958b\u767a\u3068\u5e02\u5834\u62e1\u5927\u3092\u52a0\u901f\u3055\u305b\u3066\u3044\u307e\u3059\u3002)<\/p>\n<p>\u5e02\u5834\u306e\u6291\u5236\u8981\u56e0<\/p>\n<p>1.  \u9ad8\u984d\u306a\u6cbb\u7642\u8cbb\u3068\u4e0d\u78ba\u5b9f\u306a\u511f\u9084\u72b6\u6cc1: \u6cbb\u7642\u8cbb\u304c1\u56de\u3042\u305f\u308a30\u4e07\u30c9\u30eb\u304b\u3089425\u4e07\u30c9\u30eb\u306b\u53ca\u3076\u305f\u3081\u3001\u516c\u7684\u304a\u3088\u3073\u6c11\u9593\u306e\u533b\u7642\u30b7\u30b9\u30c6\u30e0\u3067\u306e\u666e\u53ca\u304c\u59a8\u3052\u3089\u308c\u3066\u3044\u307e\u3059\u3002\u7c73\u56fd\u3067\u306f\u6210\u679c\u30d9\u30fc\u30b9\u306e\u5951\u7d04\u304c\u5c0e\u5165\u3055\u308c\u3064\u3064\u3042\u308a\u307e\u3059\u304c\u3001\u904b\u7528\u4e0a\u306e\u8907\u96d1\u3055\u304c\u8ab2\u984c\u3067\u3059\u3002\u6b27\u5dde\u3067\u306f\u4eca\u5f8c5\u5e74\u9593\u3067285\u5104\u30e6\u30fc\u30ed\uff08310\u5104\u7c73\u30c9\u30eb\uff09\u306e\u7d2f\u7a4d\u652f\u51fa\u304c\u898b\u8fbc\u307e\u308c\u3001\u4e88\u7b97\u3092\u5727\u8feb\u3057\u3001\u56fd\u5883\u3092\u8d8a\u3048\u305f\u30a2\u30af\u30bb\u30b9\u683c\u5dee\u3092\u5e83\u3052\u3066\u3044\u307e\u3059\u3002\u4e2d\u56fd\u3067\u306f\u511f\u9084\u304c\u9650\u5b9a\u7684\u3067\u3042\u308a\u3001\u591a\u304f\u306e\u60a3\u8005\u304c\u81ea\u5df1\u8cc7\u91d1\u306b\u983c\u3063\u3066\u3044\u307e\u3059\u3002<br \/>\n2.  \u8907\u96d1\u306a\u88fd\u9020\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u3068\u751f\u7523\u80fd\u529b\u306e\u5236\u7d04: \u81ea\u5df1\u7d30\u80de\u7642\u6cd5\u306f\u767d\u8840\u7403\u30a2\u30d5\u30a7\u30ec\u30fc\u30b7\u30b9\u304b\u3089\u6ce8\u5165\u307e\u30673\uff5e5\u9031\u9593\u304b\u304b\u308a\u3001\u305d\u306e\u9593\u306b\u30d6\u30ea\u30c3\u30b8\u30f3\u30b0\u5316\u5b66\u7642\u6cd5\u304c\u5fc5\u8981\u3068\u306a\u308b\u5834\u5408\u304c\u3042\u308a\u307e\u3059\u3002CDMO\u306e\u5546\u696d\u7a3c\u50cd\u7387\u306f50%\u672a\u6e80\u3067\u3042\u308a\u3001\u81e8\u5e8a\u9700\u8981\u3068\u7523\u696d\u80fd\u529b\u306e\u4e0d\u5747\u8861\u304c\u6d6e\u304d\u5f6b\u308a\u306b\u306a\u3063\u3066\u3044\u307e\u3059\u3002\u591a\u6bb5\u968e\u306e\u54c1\u8cea\u7ba1\u7406\u3084\u6975\u4f4e\u6e29\u8f38\u9001\u3082\u8ab2\u984c\u3067\u3059\u3002<br \/>\n3.  \u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u653e\u51fa\u75c7\u5019\u7fa4\uff08CRS\uff09\u3084\u795e\u7d4c\u6bd2\u6027\u306a\u3069\u306e\u5b89\u5168\u6027\u61f8\u5ff5: (\u3053\u308c\u3089\u306e\u526f\u4f5c\u7528\u306f\u3001T\u7d30\u80de\u514d\u75ab\u7642\u6cd5\u306e\u666e\u53ca\u306b\u304a\u3051\u308b\u91cd\u8981\u306a\u61f8\u5ff5\u4e8b\u9805\u3067\u3059\u3002)<br \/>\n4.  \u4ee3\u66ff\u514d\u75ab\u7642\u6cd5\u30e2\u30c0\u30ea\u30c6\u30a3\u304b\u3089\u306e\u7af6\u4e89\u5727\u529b: (\u4ed6\u306e\u514d\u75ab\u7642\u6cd5\u3068\u306e\u7af6\u5408\u3082\u5e02\u5834\u6210\u9577\u306e\u6291\u5236\u8981\u56e0\u3068\u306a\u308a\u5f97\u307e\u3059\u3002)<\/p>\n<p>\u30bb\u30b0\u30e1\u30f3\u30c8\u5206\u6790<\/p>\n<p>*   \u6cbb\u7642\u30bf\u30a4\u30d7\u5225\uff1a\u30a2\u30ed\u30b8\u30a7\u30cb\u30c3\u30af\u88fd\u5264\u306e\u53f0\u982d<br \/>\n    *   \u81ea\u5df1CAR-T\u88fd\u54c1: Kymriah\u3084Yescarta\u306a\u3069\u306e\u81ea\u5df1CAR-T\u88fd\u54c1\u306f\u30012024\u5e74\u306eT\u7d30\u80de\u514d\u75ab\u7642\u6cd5\u5e02\u5834\u30b7\u30a7\u30a2\u306e95.7%\u3092\u5360\u3081\u3001B\u7d30\u80de\u60aa\u6027\u816b\u760d\u306b\u304a\u3044\u3066\u9ad8\u3044\u594f\u52b9\u6301\u7d9a\u6027\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002\u3057\u304b\u3057\u3001\u88fd\u9020\u4e0a\u306e\u5236\u7d04\u304c\u7d76\u5bfe\u7684\u306a\u91cf\u7684\u306a\u6210\u9577\u3092\u5236\u9650\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n    *   \u30a2\u30ed\u30b8\u30a7\u30cb\u30c3\u30afCAR-T\u88fd\u5264: 2030\u5e74\u307e\u3067\u306b32.6%\u306eCAGR\u3067\u6210\u9577\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002CRISPR\u3084\u5869\u57fa\u7de8\u96c6\u6280\u8853\u306b\u3088\u308a\u3001\u79fb\u690d\u7247\u5bfe\u5bbf\u4e3b\u75c5\uff08GVHD\uff09\u306e\u61f8\u5ff5\u304c\u89e3\u6d88\u3055\u308c\u3064\u3064\u3042\u308a\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u300c\u65e2\u88fd\u300d\u88fd\u54c1\u306f\u5373\u6642\u5229\u7528\u53ef\u80fd\u3067\u3042\u308b\u305f\u3081\u3001\u6025\u6027\u816b\u760d\u5b66\u306e\u30bf\u30a4\u30e0\u30e9\u30a4\u30f3\u306b\u9069\u3057\u3066\u3044\u307e\u3059\u3002ALLO-501\u304c\u793a\u3059\u5927\u7d30\u80de\u578bB\u7d30\u80de\u30ea\u30f3\u30d1\u816b\u306b\u304a\u3051\u308b58%\u306e\u5168\u594f\u52b9\u7387\u306a\u3069\u3001\u81ea\u5df1\u7d30\u80de\u88fd\u54c1\u3068\u540c\u7b49\u306e\u6709\u52b9\u6027\u3092\u793a\u3059\u81e8\u5e8a\u30c7\u30fc\u30bf\u3082\u51fa\u3066\u3044\u307e\u3059\u3002\u30a2\u30ed\u30b8\u30a7\u30cb\u30c3\u30af\u88fd\u5264\u306e\u30b9\u30b1\u30fc\u30e9\u30d3\u30ea\u30c6\u30a3\u306f\u3001\u73fe\u5728\u306e\u6ce8\u5165\u67a0\u306e\u5236\u7d04\u3092\u89e3\u6d88\u3057\u3001\u60a3\u8005\u3042\u305f\u308a\u306e\u88fd\u9020\u30b3\u30b9\u30c8\u3092\u524a\u6e1b\u3059\u308b\u3053\u3068\u3067\u3001\u5e02\u5834\u306e\u5bfe\u8c61\u60a3\u8005\u5c64\u3092\u62e1\u5927\u3059\u308b\u3068\u671f\u5f85\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u898f\u5236\u5f53\u5c40\u3082\u30a2\u30ed\u30b8\u30a7\u30cb\u30c3\u30af\u30c7\u30fc\u30bf\u30d1\u30c3\u30b1\u30fc\u30b8\u3078\u306e\u9069\u5fdc\u3092\u9032\u3081\u3001\u8fc5\u901f\u306a\u5e02\u5834\u6295\u5165\u3092\u53ef\u80fd\u306b\u3059\u308b\u6307\u5b9a\u3092\u4e0e\u3048\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>*   \u9069\u5fdc\u75c7\u5225\uff1a\u8840\u6db2\u60aa\u6027\u816b\u760d\u306e\u512a\u4f4d\u6027\u3068\u56fa\u5f62\u816b\u760d\u306e\u6210\u9577<br \/>\n    *   \u8840\u6db2\u60aa\u6027\u816b\u760d: 2024\u5e74\u306eT\u7d30\u80de\u514d\u75ab\u7642\u6cd5\u5e02\u5834\u30b7\u30a7\u30a2\u306e83%\u3092\u5360\u3081\u307e\u3057\u305f\u3002CD19\u3001BCMA\u3001CD22\u306a\u3069\u306e\u691c\u8a3c\u6e08\u307f\u6297\u539f\u304c\u3001\u4e88\u6e2c\u53ef\u80fd\u306a\u88fd\u9020\u6210\u679c\u3068\u9ad8\u3044\u5b8c\u5168\u594f\u52b9\u7387\u306b\u8ca2\u732e\u3057\u3066\u3044\u307e\u3059\u3002\u591a\u767a\u6027\u9aa8\u9ac4\u816b\u3084\u3073\u307e\u3093\u6027\u5927\u7d30\u80de\u578bB\u7d30\u80de\u30ea\u30f3\u30d1\u816b\u306b\u304a\u3051\u308b\u65e9\u671f\u6cbb\u7642\u30e9\u30a4\u30f3\u3067\u306e\u627f\u8a8d\u306f\u3001\u60a3\u8005\u30d7\u30fc\u30eb\u3092\u62e1\u5927\u3057\u3001\u6cbb\u7642\u671f\u9593\u306e\u5ef6\u9577\u306b\u5bc4\u4e0e\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n    *   \u56fa\u5f62\u816b\u760d: 2030\u5e74\u307e\u3067\u306b35.4%\u306eCAGR\u3067\u6700\u901f\u306e\u6210\u9577\u3092\u8a18\u9332\u3059\u308b\u3068\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u6ed1\u819c\u8089\u816b\u306b\u5bfe\u3059\u308bTecelra\u306e\u627f\u8a8d\u3084\u3001\u816b\u760d\u5fae\u5c0f\u74b0\u5883\u3092\u8abf\u7bc0\u3059\u308b\u65b0\u3057\u3044\u8a2d\u8a08\u306e\u767b\u5834\u304c\u6210\u9577\u3092\u727d\u5f15\u3057\u3066\u3044\u307e\u3059\u3002\u30ca\u30ce\u30dc\u30c7\u30a3\u30d9\u30fc\u30b9\u306eCAR\u3084\u88c5\u7532T\u7d30\u80de\u306f\u3001\u514d\u75ab\u6291\u5236\u30d0\u30ea\u30a2\u3092\u7834\u58ca\u3057\u3001\u5bc6\u306a\u816b\u760d\u7d44\u7e54\u3078\u306e\u6d78\u6f64\u3092\u6539\u5584\u3059\u308b\u3053\u3068\u3092\u76ee\u6307\u3057\u3066\u3044\u307e\u3059\u3002\u814e\u7d30\u80de\u764c\u3084\u81a0\u82bd\u816b\u306b\u304a\u3051\u308b\u521d\u671f\u306e\u826f\u597d\u306a\u5146\u5019\u306f\u3001\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u306e\u62e1\u5927\u3092\u652f\u6301\u3057\u3066\u304a\u308a\u3001\u809d\u52d5\u8108\u6ce8\u5165\u306a\u3069\u306e\u5c40\u6240\u9001\u9054\u6cd5\u306f\u3001\u30aa\u30f3\u30bf\u30fc\u30b2\u30c3\u30c8\u30fb\u30aa\u30d5\u816b\u760d\u6bd2\u6027\u306e\u61f8\u5ff5\u306b\u5bfe\u51e6\u3057\u3066\u3044\u307e\u3059\u3002\u5e0c\u5c11\u4e0a\u76ae\u764c\u306b\u304a\u3051\u308b\u30d6\u30ec\u30fc\u30af\u30b9\u30eb\u30fc\u6307\u5b9a\u306f\u3001\u30aa\u30fc\u30d5\u30a1\u30f3\u30a4\u30f3\u30bb\u30f3\u30c6\u30a3\u30d6\u3092\u6d3b\u7528\u3057\u3066\u958b\u767a\u3092\u52a0\u901f\u3055\u305b\u3001\u56fa\u5f62\u816b\u760d\u304cT\u7d30\u80de\u514d\u75ab\u7642\u6cd5\u5e02\u5834\u5168\u4f53\u306b\u8ca2\u732e\u3059\u308b\u53ef\u80fd\u6027\u3092\u5e83\u3052\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5730\u57df\u5206\u6790<\/p>\n<p>*   \u5317\u7c73: 2024\u5e74\u306bT\u7d30\u80de\u514d\u75ab\u7642\u6cd5\u5e02\u5834\u30b7\u30a7\u30a2\u306e53.4%\u3092\u7dad\u6301\u3057\u307e\u3057\u305f\u3002FDA\u306e\u8fc5\u901f\u306a\u5be9\u67fb\u4f53\u5236\u3001\u30e1\u30c7\u30a3\u30b1\u30a2\u306e\u8ffd\u52a0\u652f\u6255\u3044\u3001\u8a8d\u5b9a\u6ce8\u5165\u65bd\u8a2d\u306e\u5bc6\u306a\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u304c\u305d\u306e\u80cc\u666f\u306b\u3042\u308a\u307e\u3059\u3002\u307e\u305f\u3001\u5546\u696d\u898f\u6a21\u306eGMP\u65bd\u8a2d\u304c\u96c6\u4e2d\u3057\u3066\u304a\u308a\u3001\u56fd\u5185\u8abf\u9054\u304c\u53ef\u80fd\u3067\u901a\u95a2\u9045\u5ef6\u3092\u56de\u907f\u3067\u304d\u307e\u3059\u3002<br \/>\n*   \u30a2\u30b8\u30a2\u592a\u5e73\u6d0b: 25.2%\u306eCAGR\u3067\u6700\u3082\u6025\u901f\u306a\u6210\u9577\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002\u4e2d\u56fd\u306e\u9769\u65b0\u4fc3\u9032\u653f\u7b56\u3001300\u4ef6\u4ee5\u4e0a\u306eCAR-T\u6cbb\u9a13\u3001\u5730\u65b9\u30ec\u30d9\u30eb\u3067\u306e\u627f\u8a8d\u304c\u727d\u5f15\u3057\u3066\u3044\u307e\u3059\u3002\u65e5\u672c\u306e\u8fc5\u901f\u306a\u518d\u751f\u533b\u7642\u6cd5\u306f\u5be9\u67fb\u671f\u9593\u30921\u5e74\u672a\u6e80\u306b\u77ed\u7e2e\u3057\u3001\u97d3\u56fd\u306fGMP\u65bd\u8a2d\u306e\u5efa\u8a2d\u306b\u7a0e\u984d\u63a7\u9664\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u30a4\u30f3\u30c9\u3067\u306e\u30bf\u30ea\u30ad\u30e3\u30d6\u30bf\u30b2\u30f3\u30fb\u30aa\u30fc\u30c8\u30ed\u30a4\u30bb\u30eb\u306e\u627f\u8a8d\u3068\u5b98\u6c11\u9023\u643a\u306e\u88fd\u9020\u62e0\u70b9\u306f\u3001\u4e2d\u6240\u5f97\u5c64\u5411\u3051\u306e\u5e02\u5834\u62e1\u5927\u306e\u53ef\u80fd\u6027\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u6b27\u5dde: EMA\u306e\u8abf\u548c\u304c\u9032\u3080\u4e2d\u3067\u7de9\u3084\u304b\u306a\u6210\u9577\u3092\u9042\u3052\u3066\u3044\u307e\u3059\u304c\u3001\u56fd\u30ec\u30d9\u30eb\u3067\u306e\u666e\u53ca\u306b\u306f\u3070\u3089\u3064\u304d\u304c\u3042\u308a\u307e\u3059\u3002\u4f8b\u3048\u3070\u3001\u30d5\u30e9\u30f3\u30b9\u3067\u306f\u9069\u683c\u306a\u8840\u6db2\u75be\u60a3\u60a3\u8005\u306e\u7d0430%\u306b\u666e\u53ca\u3057\u3066\u3044\u308b\u306e\u306b\u5bfe\u3057\u3001\u30a4\u30bf\u30ea\u30a2\u3067\u306f11%\u306b\u7559\u307e\u3063\u3066\u3044\u307e\u3059\u3002GoCART\u9023\u5408\u306f\u3001\u5b66\u8853\u6a5f\u95a2\u9593\u3067\u751f\u7523\u3092\u5206\u6563\u5316\u3059\u308b\u3053\u3068\u3067\u30011\u56de\u3042\u305f\u308a\u306e\u30b3\u30b9\u30c8\u3092\u534a\u6e1b\u3055\u305b\u308b\u3053\u3068\u3092\u76ee\u6307\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   \u5357\u7c73: \u30d6\u30e9\u30b8\u30eb\u306f1\u56de\u3042\u305f\u308a35,000\u7c73\u30c9\u30eb\u3068\u3044\u3046\u7834\u58ca\u7684\u306a\u4f4e\u30b3\u30b9\u30c8\u30e2\u30c7\u30eb\u3092\u793a\u3057\u3066\u304a\u308a\u3001\u30a2\u30af\u30bb\u30b9\u62e1\u5927\u306e\u305f\u3081\u306e\u5c06\u6765\u7684\u306a\u91cd\u8981\u306a\u5730\u57df\u3068\u3057\u3066\u6ce8\u76ee\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u7af6\u4e89\u74b0\u5883<\/p>\n<p>T\u7d30\u80de\u514d\u75ab\u7642\u6cd5\u5e02\u5834\u306f\u4e2d\u7a0b\u5ea6\u306e\u96c6\u4e2d\u5ea6\u3092\u793a\u3057\u3066\u304a\u308a\u30015\u3064\u306e\u591a\u56fd\u7c4d\u4f01\u696d\u304c\u4e16\u754c\u306e\u53ce\u76ca\u306e70%\u4ee5\u4e0a\u3092\u652f\u914d\u3057\u3066\u3044\u307e\u3059\u3002Novartis\u306fKymriah\u306e\u591a\u65bd\u8a2d\u9069\u5fdc\u75c7\u3067\u5148\u884c\u8005\u5229\u76ca\u3092\u4eab\u53d7\u3057\u3001Gilead\u306fYescarta\u306e\u751f\u7523\u80fd\u529b\u62e1\u5927\u8a08\u753b\u3068\u3073\u307e\u3093\u6027\u5927\u7d30\u80de\u578bB\u7d30\u80de\u30ea\u30f3\u30d1\u816b\u3078\u306e\u9069\u5fdc\u62e1\u5927\u306b\u3088\u308a\u3001\u91cf\u3067\u5148\u884c\u3057\u3066\u3044\u307e\u3059\u3002Bristol Myers Squibb\u306eBreyanzi\u306f\u3001\u9023\u7d9a\u7684\u306a\u627f\u8a8d\u3068\u81ea\u52d5\u5316\u3055\u308c\u305f\u751f\u7523\u30a2\u30c3\u30d7\u30b0\u30ec\u30fc\u30c9\u306b\u3088\u308a\u52e2\u3044\u3092\u5897\u3057\u3066\u3044\u307e\u3059\u3002Johnson &#038; Johnson\u306eCarvykti\u306f\u3001\u53b3\u683c\u306a\u5fae\u5c0f\u6b8b\u5b58\u75c5\u5909\u30c7\u30fc\u30bf\u306b\u57fa\u3065\u304d\u3001\u73fe\u57282\u756a\u76ee\u306b\u5927\u304d\u306aCAR-T\u8ca9\u58f2\u88fd\u54c1\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u4e2d\u5805\u306e\u30a4\u30ce\u30d9\u30fc\u30bf\u30fc\u4f01\u696d\uff08Allogene Therapeutics\u3001CRISPR Therapeutics\u3001Cellectis\u306a\u3069\uff09\u306f\u3001\u907a\u4f1d\u5b50\u7de8\u96c6\u3084\u514d\u75ab\u56de\u907f\u306e\u5206\u91ce\u3067\u77e5\u7684\u8ca1\u7523\u3092\u84c4\u7a4d\u3057\u3001\u30a2\u30ed\u30b8\u30a7\u30cb\u30c3\u30af\u88fd\u5264\u306b\u3088\u308b\u5e02\u5834\u7834\u58ca\u3092\u76ee\u6307\u3057\u3066\u3044\u307e\u3059\u3002\u5927\u624b\u88fd\u85ac\u4f01\u696d\u306f\u3001BioNTech\u306b\u3088\u308bAutolus\u3078\u306e2\u5104\u7c73\u30c9\u30eb\u306e\u5c11\u6570\u682a\u6295\u8cc7\u3084\u3001AbbVie\u3068Umoja\u306e14.4\u5104\u7c73\u30c9\u30eb\u306e\u30de\u30a4\u30eb\u30b9\u30c8\u30fc\u30f3\u5951\u7d04\u306b\u4ee3\u8868\u3055\u308c\u308b\u3088\u3046\u306b\u3001\u682a\u5f0f\u53d6\u5f97\u3084\u5927\u578b\u30aa\u30d7\u30b7\u30e7\u30f3\u5951\u7d04\u3092\u901a\u3058\u3066\u30ea\u30b9\u30af\u30d8\u30c3\u30b8\u3092\u884c\u3063\u3066\u3044\u307e\u3059\u3002\u88fd\u9020\u306f\u4e3b\u8981\u306a\u7af6\u4e89\u9818\u57df\u3067\u3042\u308a\u3001\u81ea\u52d5\u5316\u3055\u308c\u305f\u30b7\u30e3\u30c8\u30eb\u3084\u9589\u9396\u7cfb\u30d0\u30a4\u30aa\u30ea\u30a2\u30af\u30bf\u30fc\u304c\u30ea\u30fc\u30c9\u30bf\u30a4\u30e0\u3092\u77ed\u7e2e\u3057\u3001\u30ed\u30c3\u30c8\u306e\u6210\u529f\u7387\u3092\u5411\u4e0a\u3055\u305b\u3066\u3044\u307e\u3059\u3002\u5b66\u8853\u6a5f\u95a2\u306f\u3001\u75c5\u9662\u514d\u9664\u5236\u5ea6\u3092\u6d3b\u7528\u3057\u3066\u30b3\u30b9\u30c8\u30d9\u30fc\u30b9\u306e\u88fd\u54c1\u3092\u63d0\u4f9b\u3059\u308b\u3053\u3068\u3067\u3001\u5546\u696d\u4fa1\u683c\u306e\u4e0a\u9650\u306b\u5727\u529b\u3092\u304b\u3051\u3001\u30a2\u30af\u30bb\u30b9\u3092\u6c11\u4e3b\u5316\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u308c\u3089\u306e\u52d5\u5411\u304c\u3001T\u7d30\u80de\u514d\u75ab\u7642\u6cd5\u5e02\u5834\u306e\u7af6\u4e89\u69cb\u9020\u3092\u5f62\u6210\u3057\u3001\u7d99\u7d9a\u7684\u306a\u7814\u7a76\u958b\u767a\u306e\u591a\u69d8\u5316\u3092\u4fc3\u9032\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>T\u7d30\u80de\u514d\u75ab\u7642\u6cd5\u696d\u754c\u306e\u4e3b\u8981\u4f01\u696d<\/p>\n<p>*   Novartis AG<br \/>\n*   Gilead Sciences<br \/>\n*   Bristol Myers Squibb<br \/>\n*   Johnson &#038; Johnson<br \/>\n*   Iovance Biotherapeutics<\/p>\n<p>\u6700\u8fd1\u306e\u696d\u754c\u52d5\u5411<\/p>\n<p>*   2025\u5e743\u6708: FDA\u306f\u3001\u518d\u767a\/\u96e3\u6cbb\u6027B\u7d30\u80de\u6025\u6027\u30ea\u30f3\u30d1\u6027\u767d\u8840\u75c5\u306e\u6210\u4eba\u60a3\u8005\u5411\u3051\u306bAucatzyl\uff08\u30aa\u30d9\u30ab\u30d6\u30bf\u30b2\u30f3\u30fb\u30aa\u30fc\u30c8\u30ed\u30a4\u30bb\u30eb\uff09\u3092\u627f\u8a8d\u3057\u307e\u3057\u305f\u300263%\u306e\u5b8c\u5168\u5bdb\u89e3\u7387\u3092\u9054\u6210\u3057\u3066\u3044\u307e\u3059\u3002<br \/>\n*   2025\u5e742\u6708: Cellectis\u306f\u3001UCART22\u304a\u3088\u3073UCART20x22\u306e\u826f\u597d\u306a\u7b2c1\u76f8\u30c7\u30fc\u30bf\u3092\u5831\u544a\u3057\u3001\u4e21\u88fd\u54c1\u304c\u30c7\u30e5\u30a2\u30eb\u30aa\u30fc\u30d5\u30a1\u30f3\u30c9\u30e9\u30c3\u30b0\u6307\u5b9a\u3092\u53d7\u3051\u307e\u3057\u305f\u3002<br \/>\n*   2024\u5e742\u6708: BioNTech\u3068Autolus\u306f\u30012\u5104\u7c73\u30c9\u30eb\u306e\u682a\u5f0f\u6295\u8cc7\u3092\u542b\u30802\u51045000\u4e07\u7c73\u30c9\u30eb\u306eCAR-T\u5171\u540c\u7814\u7a76\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002<\/p>\n<p>\u672c\u30ec\u30dd\u30fc\u30c8\u306f\u3001T\u7d30\u80de\u514d\u75ab\u7642\u6cd5\u5e02\u5834\u306e\u8a73\u7d30\u306a\u5206\u6790\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u5e02\u5834\u306f\u30012030\u5e74\u307e\u3067\u306b327.5\u5104\u7c73\u30c9\u30eb\u306b\u9054\u3057\u3001\u5e74\u5e73\u5747\u6210\u9577\u7387\uff08CAGR\uff0935.33%\u3067\u6025\u901f\u306a\u62e1\u5927\u304c\u4e88\u6e2c\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u5e02\u5834\u306e\u6210\u9577\u3092\u727d\u5f15\u3059\u308b\u4e3b\u8981\u56e0\u3068\u3057\u3066\u306f\u3001\u4e16\u754c\u7684\u306a\u764c\u60a3\u8005\u6570\u306e\u5897\u52a0\u3068\u9ad8\u9f62\u5316\u3001T\u7d30\u80de\u7642\u6cd5\u306e\u9069\u5fdc\u75c7\u62e1\u5927\u3001\u6709\u5229\u306a\u898f\u5236\u7d4c\u8def\u3068\u8fc5\u901f\u627f\u8a8d\u30d7\u30ed\u30b0\u30e9\u30e0\u306e\u5b58\u5728\u304c\u6319\u3052\u3089\u308c\u307e\u3059\u3002\u3055\u3089\u306b\u3001\u7d30\u80de\u30fb\u907a\u4f1d\u5b50\u6cbb\u7642\u30a4\u30f3\u30d5\u30e9\u3078\u306e\u6295\u8cc7\u5897\u52a0\u3001\u7d30\u80de\u5de5\u5b66\u304a\u3088\u3073\u88fd\u9020\u81ea\u52d5\u5316\u306b\u304a\u3051\u308b\u6280\u8853\u9032\u6b69\u3001\u88fd\u85ac\u30fb\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3068\u5b66\u8853\u6a5f\u95a2\u9593\u306e\u6226\u7565\u7684\u63d0\u643a\u3082\u91cd\u8981\u306a\u63a8\u9032\u529b\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u4e00\u65b9\u3067\u3001\u5e02\u5834\u306b\u306f\u8ab2\u984c\u3082\u5b58\u5728\u3057\u307e\u3059\u3002\u9ad8\u984d\u306a\u6cbb\u7642\u8cbb\u3068\u4e0d\u78ba\u5b9f\u306a\u511f\u9084\u72b6\u6cc1\u3001\u8907\u96d1\u306a\u88fd\u9020\u30b5\u30d7\u30e9\u30a4\u30c1\u30a7\u30fc\u30f3\u3068\u751f\u7523\u80fd\u529b\u306e\u5236\u7d04\u304c\u5e02\u5834\u306e\u8ab2\u984c\u3067\u3059\u3002\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u653e\u51fa\u75c7\u5019\u7fa4\uff08CRS\uff09\u3084\u795e\u7d4c\u6bd2\u6027\u3068\u3044\u3063\u305f\u5b89\u5168\u6027\u3078\u306e\u61f8\u5ff5\u3001\u4ee3\u66ff\u514d\u75ab\u7642\u6cd5\u30e2\u30c0\u30ea\u30c6\u30a3\u304b\u3089\u306e\u7af6\u4e89\u5727\u529b\u3082\u6291\u5236\u8981\u56e0\u3068\u3057\u3066\u6307\u6458\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u6cbb\u7642\u30bf\u30a4\u30d7\u5225\u3067\u306f\u3001\u81ea\u5bb6CAR-T\u88fd\u54c1\u304c\u73fe\u5728\u306e\u5546\u696d\u53ce\u76ca\u306e95.7%\u3092\u5360\u3081\u512a\u4f4d\u3067\u3059\u304c\u3001\u540c\u7a2e\u7570\u7cfb\uff08allogeneic\uff09T\u7d30\u80de\u7642\u6cd5\u304c\u6700\u3082\u6025\u901f\u306b\u6210\u9577\u3057\u3066\u3044\u308b\u30b5\u30d6\u30bb\u30b0\u30e1\u30f3\u30c8\u3067\u3059\u3002\u9069\u5fdc\u75c7\u5225\u3067\u306f\u3001\u8840\u6db2\u60aa\u6027\u816b\u760d\u304c\u4e3b\u8981\u3067\u3059\u304c\u3001\u56fa\u5f62\u816b\u760d\u3001\u81ea\u5df1\u514d\u75ab\u75be\u60a3\u3001\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u306a\u3069\u3078\u306e\u9069\u7528\u62e1\u5927\u3082\u671f\u5f85\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u5730\u57df\u5225\u3067\u306f\u3001\u30a2\u30b8\u30a2\u592a\u5e73\u6d0b\u5730\u57df\u304c\u4e2d\u56fd\u3001\u65e5\u672c\u3001\u97d3\u56fd\u3067\u306e\u627f\u8a8d\u52a0\u901f\u3068\u751f\u7523\u80fd\u529b\u5897\u5f37\u306b\u3088\u308a\u3001\u5e74\u5e73\u5747\u6210\u9577\u738725.2%\u3067\u6700\u3082\u9ad8\u3044\u6210\u9577\u304c\u898b\u8fbc\u307e\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u6cbb\u7642\u8cbb\u306f30\u4e07\u30c9\u30eb\u304b\u3089425\u4e07\u30c9\u30eb\u3068\u9ad8\u984d\u3067\u3042\u308a\u3001\u7279\u306b\u65b0\u8208\u5e02\u5834\u3067\u306f\u511f\u9084\u67a0\u304c\u4e0d\u900f\u660e\u3067\u3042\u308b\u3053\u3068\u304c\u5e83\u7bc4\u306a\u30a2\u30af\u30bb\u30b9\u3078\u306e\u5927\u304d\u306a\u969c\u58c1\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002\u5b89\u5168\u6027\u306b\u95a2\u3057\u3066\u306f\u3001\u30b5\u30a4\u30c8\u30ab\u30a4\u30f3\u653e\u51fa\u75c7\u5019\u7fa4\u3068\u795e\u7d4c\u6bd2\u6027\u304c\u5f15\u304d\u7d9a\u304d\u6700\u5927\u306e\u61f8\u5ff5\u4e8b\u9805\u3067\u3042\u308a\u3001\u5e02\u8ca9\u5f8c\u8abf\u67fb\u306e\u5ef6\u9577\u3084\u5c02\u9580\u7684\u306aICU\u4f53\u5236\u306e\u6574\u5099\u304c\u6c42\u3081\u3089\u308c\u3066\u3044\u307e\u3059\u3002\u88fd\u9020\u7d4c\u6e08\u3092\u518d\u5b9a\u7fa9\u3059\u308b\u6280\u8853\u7684\u30b7\u30d5\u30c8\u3068\u3057\u3066\u3001\u81ea\u52d5\u5316\u3055\u308c\u305f\u30af\u30ed\u30fc\u30ba\u30c9\u30b7\u30b9\u30c6\u30e0\u30d0\u30a4\u30aa\u30ea\u30a2\u30af\u30bf\u30fc\u3084\u907a\u4f1d\u5b50\u7de8\u96c6\u3055\u308c\u305f\u540c\u7a2e\u7570\u7cfb\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u304c\u6ce8\u76ee\u3055\u308c\u3066\u304a\u308a\u3001\u3053\u308c\u3089\u306f\u751f\u7523\u30b3\u30b9\u30c8\u524a\u6e1b\u3068\u65e2\u88fd\u85ac\uff08off-the-shelf\uff09\u63d0\u4f9b\u3092\u76ee\u6307\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n<p>\u7af6\u4e89\u74b0\u5883\u3067\u306f\u3001Novartis AG\u3001Gilead Sciences (Kite Pharma)\u3001Bristol Myers Squibb\u3001Johnson &#038; Johnson \/ Legend Biotech\u306a\u3069\u3001\u591a\u6570\u306e\u4e3b\u8981\u88fd\u85ac\u30fb\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u304c\u5e02\u5834\u306b\u53c2\u5165\u3057\u3066\u3044\u307e\u3059\u3002\u30ec\u30dd\u30fc\u30c8\u3067\u306f\u3001\u3053\u308c\u3089\u306e\u4f01\u696d\u306e\u30b0\u30ed\u30fc\u30d0\u30eb\u304a\u3088\u3073\u5e02\u5834\u30ec\u30d9\u30eb\u306e\u6982\u8981\u3001\u4e3b\u8981\u30bb\u30b0\u30e1\u30f3\u30c8\u3001\u8ca1\u52d9\u60c5\u5831\u3001\u6226\u7565\u3001\u88fd\u54c1\u30fb\u30b5\u30fc\u30d3\u30b9\u3001\u6700\u8fd1\u306e\u52d5\u5411\u306a\u3069\u304c\u8a73\u7d30\u306b\u5206\u6790\u3055\u308c\u3066\u3044\u307e\u3059\u3002\u5e02\u5834\u306f\u3001\u672a\u5145\u8db3\u306e\u30cb\u30fc\u30ba\u3078\u306e\u5bfe\u5fdc\u3068\u65b0\u305f\u306a\u6a5f\u4f1a\u306e\u5275\u51fa\u3092\u901a\u3058\u3066\u3001\u4eca\u5f8c\u3082\u9032\u5316\u3057\u7d9a\u3051\u308b\u3068\u4e88\u6e2c\u3055\u308c\u307e\u3059\u3002<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/92254"}],"collection":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/comments?post=92254"}],"version-history":[{"count":1,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/92254\/revisions"}],"predecessor-version":[{"id":92257,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/posts\/92254\/revisions\/92257"}],"wp:attachment":[{"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/media?parent=92254"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/categories?post=92254"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketresearch.co.jp\/insights\/wp-json\/wp\/v2\/tags?post=92254"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}